


Healthcare News Roundup: Oncology
HSMN NewsFeed - 28 Jun 2021
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology
B dot Medical Successfully Develops Compact Bending Magnet for Proton Beam Using Superconducting Technology
HSMN NewsFeed - 17 Jun 2021
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
KaliVir Immunotherapeutics Appoints Drs. Terry Hermiston and Jon Wigginton to Board of Directors
HSMN NewsFeed - 17 Jun 2021
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
HSMN NewsFeed - 16 Jun 2021
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline
HSMN NewsFeed - 7 Jun 2021
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
HSMN NewsFeed - 1 Jun 2021
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
Kineta Closes $10 Million Financing Round to Advance Anti-VISTA Immuno-oncology Program
HSMN NewsFeed - 26 May 2021
RayStation Latest Release, Now with Support for Accuray's CyberKnife(R) System
RayStation Latest Release, Now with Support for Accuray's CyberKnife(R) System
HSMN NewsFeed - 17 May 2021
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
AffyImmune Therapeutics' AIC100 Granted Fast Track Designation for Treating Thyroid Cancer
HSMN NewsFeed - 11 May 2021
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
